Guillain-Barré and Miller Fisher syndromes-new diagnostic classification. B Wakerley, A Uncini, N Yuki, GBSC Group Nature Reviews Neurology, 2014 | 527 | 2014 |
Diagnosis and management of Guillain–Barré syndrome in ten steps SE Leonhard, MR Mandarakas, FAA Gondim, K Bateman, MLB Ferreira, ... Nature Reviews Neurology 15 (11), 671-683, 2019 | 503 | 2019 |
Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome N Shahrizaila, N Yuki Journal of Neurology, Neurosurgery & Psychiatry 84 (5), 576-583, 2013 | 260 | 2013 |
Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis V Nesin, G Wiley, M Kousi, EC Ong, T Lehmann, DJ Nicholl, M Suri, ... Proceedings of the National Academy of Sciences 111 (11), 4197-4202, 2014 | 229 | 2014 |
Guillain-Barré syndrome N Shahrizaila, HC Lehmann, S Kuwabara The lancet 397 (10280), 1214-1228, 2021 | 224 | 2021 |
Regional variation of Guillain-Barré syndrome AY Doets, C Verboon, B Van Den Berg, T Harbo, DR Cornblath, ... Brain 141 (10), 2866-2877, 2018 | 209 | 2018 |
Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes A Uncini, N Shahrizaila, S Kuwabara Journal of Neurology, Neurosurgery & Psychiatry 88 (3), 266-271, 2017 | 116 | 2017 |
Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: criteria sets and sparse linear discriminant analysis A Uncini, L Ippoliti, N Shahrizaila, Y Sekiguchi, S Kuwabara Clinical Neurophysiology 128 (7), 1176-1183, 2017 | 106 | 2017 |
International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in … BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ... Journal of the Peripheral Nervous System 22 (2), 68-76, 2017 | 97 | 2017 |
Guillain-Barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder N Shahrizaila, N Yuki Journal of Biomedicine and Biotechnology 2011, 2010 | 94 | 2010 |
Respiratory involvement in inherited primary muscle conditions N Shahrizaila, WJM Kinnear, AJ Wills Journal of Neurology, Neurosurgery & Psychiatry 77 (10), 1108-1115, 2006 | 70 | 2006 |
Current treatment practice of Guillain-Barré syndrome C Verboon, AY Doets, G Galassi, A Davidson, W Waheed, Y Péréon, ... Neurology 93 (1), e59-e76, 2019 | 67 | 2019 |
Amyotrophic lateral sclerosis and motor neuron syndromes in Asia N Shahrizaila, G Sobue, S Kuwabara, SH Kim, C Birks, DS Fan, JS Bae, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (8), 821-830, 2016 | 61 | 2016 |
Serial peripheral nerve ultrasound in Guillain–Barré syndrome SNO Razali, T Arumugam, N Yuki, FI Rozalli, KJ Goh, N Shahrizaila Clinical Neurophysiology 127 (2), 1652-1656, 2016 | 47 | 2016 |
Two sets of nerve conduction studies may suffice in reaching a reliable electrodiagnosis in Guillain–Barré syndrome N Shahrizaila, KJ Goh, S Abdullah, R Kuppusamy, N Yuki Clinical Neurophysiology 124 (7), 1456-1459, 2013 | 47 | 2013 |
Significance of Beevor’s sign in facioscapulohumeral dystrophy and other neuromuscular diseases N Shahrizaila, AJ Wills Journal of Neurology, Neurosurgery & Psychiatry 76 (6), 869-870, 2005 | 47 | 2005 |
Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes N Shahrizaila, N Kokubun, S Sawai, T Umapathi, YC Chan, S Kuwabara, ... Neurology 83 (2), 118-124, 2014 | 40 | 2014 |
Relationship between ultrasonographic nerve morphology and severity of diabetic sensorimotor polyneuropathy T Arumugam, SNO Razali, SR Vethakkan, FI Rozalli, N Shahrizaila European journal of neurology 23 (2), 354-360, 2016 | 36 | 2016 |
Anti‐GQ 1b antibody syndrome: anti‐ganglioside complex reactivity determines clinical spectrum Y Fukami, AHY Wong, K Funakoshi, AY Safri, N Shahrizaila, N Yuki European journal of neurology 23 (2), 320-326, 2016 | 34 | 2016 |
The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action N Shahrizaila, N Yuki Expert opinion on pharmacotherapy 12 (10), 1551-1560, 2011 | 34 | 2011 |